An interesting observation has been that specific variants in the HNF1B gene (formerly TCF2) have been demonstrated to be associated both with the risk of prostate cancer[9], [10], [11] and the risk of T2D[9], [12] with the effects being in the opposite direction for these two phenotypes. This evidence concerns the gene HNF1B and Familial prostate cancer.